Product Code: ETC089507 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Indonesia antiparasitics drugs market is expected to witness a modest growth during the forecast period 2025-2031. The market has been growing due to increasing prevalence of various parasitic infections in the country, rising awareness among people about preventive measures, and availability of effective drugs. High investment by government for healthcare services, presence of strong distribution channels and development of new products are some other factors that are likely to boost growth in this sector over the coming years.
Some trends driving the Indonesia antiparasitics drug market include increasing incidence of zoonotic diseases such as leishmaniasis and malaria; rise in demand for innovative medicines from local pharmaceutical companies; increase in expenditure on healthcare infrastructure; expansion of private health insurance networks; emergence of generic medicine manufacturing units across Indonesia; easy accessibility & affordability for generic medications which encourage consumers shift towards these treatments owing to their low cost when compared with patented medicines etc.
The major drivers contributing towards the growth of India Antiparasitic Drugs Market include an increase in incidence rate and prevalence rate associated with infectious diseases such as malaria, schistosomiasis, trichomoniasis etc., rapid urbanization leading individuals into contact with more parasites than ever before, even greater access to better medical facilities like vaccination programs against certain parasite related illnesses, increased spending capacity coupled with widespread availability at affordable prices have further propelled sales within this sector. Additionally, advancements made via research activities offering new solutions along with supportive government regulations have created conducive environment for industry developments.
Due to COVID-19 pandemic outbreak the entire global economy has suffered massive losses both financially as well as human resources wise. As a result most industries faced serious challenges that led them toward downfall or stagnation however there were few domains including pharmaceuticals which not only fought back but also gained notable profits out it. Since its outbreak antimicrobial resistance (AMR) was one problem often highlighted by WHO therefore many governments across globe rushed toward production/procurement/distribution policies regarding antibiotics & antiviral agents while simultaneously introducing guidelines related infection prevention measures. Moreover ongoing vaccinations & clinical trials offered additional support resulting into healthy revenue generation opportunities within antimicrobial segment thereby promoting overall industry during crisis situation.
Limited access to quality antiparasitics drugs due to inadequate supplies, high prices, and poor availability in remote areas. Lack of knowledge about the proper use and disposal of these drugs among healthcare providers and patients alike. Low levels of awareness regarding the importance of adequate screening and treatment for parasites in Indonesia leading to a lack of timely diagnosis and insufficient compliance with prescribed treatments plans for parasitic diseases. Growing resistance towards existing antiparasitic drugs due to overuse or mismanagement, leading to a need for newer drug formulations with improved efficacy profiles against particular parasites such as helminths, protozoa, ectoparasites etc.
Pfizer Inc., Merck & Co., Johnson & Johnson Services Inc., Sanofi S/A, Novartis AG, Bayer AG, GlaxoSmithKline PLC (GSK) are some international players operating in this market space.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Antiparasitics Drugs Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Indonesia Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Indonesia Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Indonesia Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Indonesia Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Antiparasitics Drugs Market Trends |
6 Indonesia Antiparasitics Drugs Market, By Types |
6.1 Indonesia Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2018 - 2031F |
6.1.3 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Oral, 2018 - 2031F |
6.1.4 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2018 - 2031F |
6.1.5 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Topical, 2018 - 2031F |
6.2 Indonesia Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2018 - 2031F |
6.2.3 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2018 - 2031F |
6.2.4 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Others, 2018 - 2031F |
6.3 Indonesia Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2031F |
6.3.3 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2018 - 2031F |
6.3.4 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2018 - 2031F |
7 Indonesia Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Indonesia Antiparasitics Drugs Market Export to Major Countries |
7.2 Indonesia Antiparasitics Drugs Market Imports from Major Countries |
8 Indonesia Antiparasitics Drugs Market Key Performance Indicators |
9 Indonesia Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Indonesia Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Indonesia Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Indonesia Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Antiparasitics Drugs Market - Competitive Landscape |
10.1 Indonesia Antiparasitics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |